SCHEMBL27866771

SCHEMBL27866771

CC(=O)N1CCCC(N(C)C(=O)OC(C)(C)C)C1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.53
▸ USP30 Q70CQ3 3/20 0.40
▸ SPR P35270 5/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KDM4D Q6B0I6 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.36
▸ DDB1 Q16531 1/20 0.36
▸ CRBN Q96SW2 1/20 0.36
▸ JAK2 O60674 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ RET P07949 1/20 0.35
▸ AAK1 Q2M2I8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3296587 0.91 HSD11B1 (0.62) HSD11B1USP30SPRKDM4DPDE10A
SCHEMBL1467761 0.89 HSD11B1 (0.53) HSD11B1USP30SPRMEN1ALDH1A1
SCHEMBL18711272 0.85 HSD11B1 (0.50) HSD11B1USP30SPRKDM4DDDB1
SCHEMBL13561970 0.82 HSD11B1 (0.49) HSD11B1USP30SPRMEN1ALDH1A1
SCHEMBL10196708 0.82 HSD11B1 (0.49) HSD11B1USP30SPRMEN1ALDH1A1
SCHEMBL10196718 0.82 HSD11B1 (0.49) HSD11B1USP30SPRMEN1ALDH1A1
SCHEMBL26666679 0.82 HSD11B1 (0.54) HSD11B1USP30SPRHPGDKDM4D
SCHEMBL13738053 0.79 HSD11B1 (0.62) HSD11B1USP30SPRMEN1KMT2A
SCHEMBL21285788 0.79 HSD11B1 (0.69) HSD11B1USP30SPRMEN1ALDH1A1
SCHEMBL5242729 0.79 HSD11B1 (0.62) HSD11B1USP30SPRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109897038-B Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 艾伯维爱尔兰无限公司 2022-04-05 — — CN disclosed
CN-108175749-B Melt-extruded solid dispersions containing apoptosis-inducing agents 艾伯维爱尔兰无限公司 2021-09-10 — — CN disclosed
CN-102448959-A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBOTT LAB 2012-05-09 — — CN disclosed
Send feedback